1. Home
  2. CIK vs CDXS Comparison

CIK vs CDXS Comparison

Compare CIK & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Credit Suisse Asset Management Income Fund Inc.

CIK

Credit Suisse Asset Management Income Fund Inc.

HOLD

Current Price

$2.82

Market Cap

154.6M

Sector

Finance

ML Signal

HOLD

Logo Codexis Inc.

CDXS

Codexis Inc.

HOLD

Current Price

$1.68

Market Cap

141.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CIK
CDXS
Founded
1987
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Major Chemicals
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
154.6M
141.8M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
CIK
CDXS
Price
$2.82
$1.68
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
115.4K
1.1M
Earning Date
01-01-0001
11-06-2025
Dividend Yield
9.03%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$52,932,000.00
Revenue This Year
N/A
$15.64
Revenue Next Year
N/A
$5.23
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.50
$1.52
52 Week High
$3.19
$5.51

Technical Indicators

Market Signals
Indicator
CIK
CDXS
Relative Strength Index (RSI) 48.48 43.43
Support Level $2.78 $1.60
Resistance Level $2.84 $1.75
Average True Range (ATR) 0.03 0.10
MACD 0.00 0.01
Stochastic Oscillator 50.00 22.86

Price Performance

Historical Comparison
CIK
CDXS

About CIK Credit Suisse Asset Management Income Fund Inc.

Credit Suisse Asset Mgmt Income Fund Inc is a closed-end management investment company. The investment objective of the fund is to provide current income consistent with the preservation of capital. Credit Suisse serves as an investment adviser for the fund. Asset Management offers a wide range of investment products and functions across asset classes and investment styles. The division manages various regional portfolios, mutual funds, and other investment vehicles for governments, institutions, corporations and individuals.

About CDXS Codexis Inc.

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

Share on Social Networks: